AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Physician looking out a window

Physicians in these 10 specialties are less likely to quit

| 6 Min Read
Perturbed patient holds up hands during an appointment

Only 1 in 3 doctors trusts insurers’ prior authorization promises

| 6 Min Read
Senior man looks off into the distance

As population ages, need for practicing geriatricians grows more acute

| 5 Min Read
Jason Mitchell, MD, featured on "Health vs. Hype" AMA podcast (episode 3)

9 things patients should know about taking creatine

| 5 Min Read